Horváth Tamás, Rózsa Zsófia Borbála, Viskolcz Béla, Mucsi Zoltán, Szőri Milán
Institute of Chemistry, University of Miskolc, Egyetemváros A/2, Miskolc H-3515, Hungary.
Higher Education and Industrial Cooperation Centre, University of Miskolc, H-3515 Miskolc, Hungary.
ACS Omega. 2025 Jul 21;10(29):32404-32412. doi: 10.1021/acsomega.5c04726. eCollection 2025 Jul 29.
Nuclear incidents release hazardous Sr, posing risks to health. Seeking chelating agents capable of removing Sr is critical for nuclear safety and development. In our work, the main goal was to develop a substantial yet straightforward method to support the design of viable, in vivo stable chelating agents for radiostrontium. To investigate, we implemented the highly accurate density functional theory (DFT)-based rSCAN-3c composite method and isothermal titration calorimetry (ITC). Our methods were validated through the characterization of calcium (Ca) and strontium (Sr) chelation by ethylenediaminetetraacetic acid (EDTA). The chosen DFT model was able to approximate the literature value (ΔΔ of 15.4 kJ/mol for the ion exchange reaction from Ca-EDTA to Sr-EDTA, compared to the literature value of 11.0 kJ/mol), while the thermodynamic parameters obtained from the ITC study of calcium EDTA chelation were almost identical to those found in the literature. With the validated methods, strontium chelation by (7,16-bis-malonate)-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane-bis-malonic acid (Decorporol) was first synthesized and then examined. Our DFT calculations revealed that the exchange reaction from Ca to Sr with Decorporol has an exergonic (-14.1 kJ/mol) Gibbs free energy profile, which is also approved by the experimental Gibbs free energy change of -34.5 ± 1.1 kJ/mol obtained from the ITC measurements. Measurements at elevated temperatures and physiological conditions did not impact chelation significantly; therefore, in vivo application of the chelating agent is feasible.
核事故会释放有害的锶,对健康构成风险。寻找能够去除锶的螯合剂对于核安全与发展至关重要。在我们的工作中,主要目标是开发一种实用且直接的方法,以支持设计用于放射性锶的、在体内稳定的可行螯合剂。为了进行研究,我们采用了基于高精度密度泛函理论(DFT)的rSCAN - 3c复合方法和等温滴定量热法(ITC)。我们的方法通过乙二胺四乙酸(EDTA)对钙(Ca)和锶(Sr)螯合作用的表征进行了验证。所选的DFT模型能够近似文献值(从Ca - EDTA到Sr - EDTA的离子交换反应的ΔΔ为15.4 kJ/mol,而文献值为11.0 kJ/mol),同时从ITC对钙 - EDTA螯合研究中获得的热力学参数与文献中发现的几乎相同。利用经过验证的方法,首先合成了(7,16 - 双 - 丙二酸酯)- 1,4,10,13 - 四氧杂 - 7,16 - 二氮杂环十八烷 - 双 - 丙二酸(去铁胺)对锶的螯合物,然后进行了研究。我们的DFT计算表明,去铁胺从Ca到Sr的交换反应具有一个放能(-14.1 kJ/mol)的吉布斯自由能分布,这也得到了ITC测量获得的-34.5 ± 1.1 kJ/mol的实验吉布斯自由能变化的证实。在高温和生理条件下的测量对螯合作用没有显著影响;因此,该螯合剂在体内的应用是可行的。